|
Name |
Dihydrotrichotetronine
|
Molecular Formula | C28H34O8 | |
IUPAC Name* |
(1R,4S,5Z,7R,8S)-7-[(E)-hex-4-enoyl]-3-hydroxy-8-[(2S)-3-hydroxy-2,4-dimethyl-5-oxofuran-2-yl]-5-[(2E,4E)-1-hydroxyhexa-2,4-dienylidene]-1,3-dimethylbicyclo[2.2.2]octane-2,6-dione
|
|
SMILES |
C/C=C/CCC(=O)[C@@H]1[C@H]([C@H]2/C(=C(\C=C\C=C\C)/O)/C(=O)[C@@]1(C(=O)C2(C)O)C)[C@]3(C(=C(C(=O)O3)C)O)C
|
|
InChI |
InChI=1S/C28H34O8/c1-7-9-11-13-16(29)18-20-21(28(6)22(31)15(3)24(33)36-28)19(17(30)14-12-10-8-2)26(4,23(18)32)25(34)27(20,5)35/h7-11,13,19-21,29,31,35H,12,14H2,1-6H3/b9-7+,10-8+,13-11+,18-16-/t19-,20-,21-,26-,27?,28+/m1/s1
|
|
InChIKey |
KCPUSSJDCHTZSH-WLBJBHMBSA-N
|
|
Synonyms |
Dihydrotrichotetronine
|
|
CAS | NA | |
PubChem CID | 139583245 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 498.6 | ALogp: | 2.8 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 138.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 36 | QED Weighted: | 0.117 |
Caco-2 Permeability: | -4.918 | MDCK Permeability: | 0.00006210 |
Pgp-inhibitor: | 0.97 | Pgp-substrate: | 0.438 |
Human Intestinal Absorption (HIA): | 0.029 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.867 | Plasma Protein Binding (PPB): | 90.16% |
Volume Distribution (VD): | 0.969 | Fu: | 9.47% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.364 |
CYP2C19-inhibitor: | 0.019 | CYP2C19-substrate: | 0.726 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.051 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.038 |
CYP3A4-inhibitor: | 0.912 | CYP3A4-substrate: | 0.867 |
Clearance (CL): | 7.331 | Half-life (T1/2): | 0.43 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.112 |
Drug-inuced Liver Injury (DILI): | 0.701 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.953 | Maximum Recommended Daily Dose: | 0.889 |
Skin Sensitization: | 0.052 | Carcinogencity: | 0.85 |
Eye Corrosion: | 0.743 | Eye Irritation: | 0.126 |
Respiratory Toxicity: | 0.94 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003250 | 0.776 | D0E9KA | 0.221 | ||||
ENC004085 | 0.727 | D0J2NK | 0.215 | ||||
ENC004086 | 0.667 | D0WY9N | 0.212 | ||||
ENC002144 | 0.536 | D03ZFG | 0.209 | ||||
ENC003128 | 0.484 | D08NQZ | 0.201 | ||||
ENC003762 | 0.469 | D04VEJ | 0.200 | ||||
ENC005696 | 0.447 | D02GAC | 0.199 | ||||
ENC003500 | 0.439 | D0R6RC | 0.199 | ||||
ENC005202 | 0.422 | D05QDC | 0.195 | ||||
ENC003887 | 0.399 | D0H2MO | 0.195 |